PMC8202262_01
Radiologic and medication details of patient 1.. (a) Radiologic details; (b) details of medication history.
10.1177_17588359211018028-fig1.jpg
PMC8202262_01_10.1177_17588359211018028-fig1.jpg
fig1-17588359211018028
Chest computed tomography (CT) imaging showed bipulmonal ground-glass opacities (Figure 1). At the time of this case report, the latest positron emission tomography (PET) CT scan showed no evidence for recurrent pneumonitis and showed stable disease (Figure 1).
PMC8202262_02
Radiologic and medication details of patient 2.. (a) Radiologic details; (b) details of medication history.
10.1177_17588359211018028-fig2.jpg
PMC8202262_02_10.1177_17588359211018028-fig2.jpg
fig2-17588359211018028
The CT scan of the thorax showed basal bipulmonal ground-glass opacities (Figure 2). The prednisolone dose was reduced to 5 mg daily over the course of the treatment, and the follow-up PET scan showed stable disease 3 months after re-exposition (Figure 2).
PMC8202262_03
Radiologic and medication details of patient 3.. (a) Radiologic details; (b) details of medication history.
10.1177_17588359211018028-fig3.jpg
PMC8202262_03_10.1177_17588359211018028-fig3.jpg
fig3-17588359211018028
Again, thoracic CT scan showed bipulmonal ground-glass opacities (Figure 3).